0430-0979Level 3
Atelvia (risedronate sodium)
**Product type:** Human Prescription Drug
**Active ingredient:** RISEDRONATE SODIUM HEMIPENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE
**Strength:** 30.1; 4.9 mg/1; mg/1
**Dosage form:** Tablet, Delayed Release
**Route:** Oral
**Labeler:** Allergan, Inc.
**Marketing category:** NDA (NDA022560)
**Pharmacologic class:** Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]
GET
/api/v1/systems/ndc_fda/nodes/0430-0979Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.